Found: 126
Select item for more details and to access through your institution.
Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0182115
- By:
- Publication type:
- Article
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0921-2
- By:
- Publication type:
- Article
Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21).
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0293465
- By:
- Publication type:
- Article
Clinical implications of the Third Universal Definition of Myocardial Infarction.
- Published in:
- Postgraduate Medical Journal, 2014, v. 90, n. 1067, p. 502, doi. 10.1136/postgradmedj-2012-302976rep
- By:
- Publication type:
- Article
Cholesterol‐lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost‐effective?
- Published in:
- Medical Journal of Australia, 2002, v. 177, n. 8, p. 420, doi. 10.5694/j.1326-5377.2002.tb04883.x
- By:
- Publication type:
- Article
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES.
- Published in:
- European Journal of Preventive Cardiology, 2024, v. 31, n. 10, p. e75, doi. 10.1093/eurjpc/zwae110
- By:
- Publication type:
- Article
Üçüncü Evrensel Miyokart Enfarktüsü Tanımı.
- Published in:
- Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi, 2013, v. 41, p. 129
- By:
- Publication type:
- Article
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 39, p. 3947, doi. 10.1093/eurheartj/ehac374
- By:
- Publication type:
- Article
Alirocumab after acute coronary syndrome in patients with a history of heart failure.
- Published in:
- European Heart Journal, 2022, v. 43, n. 16, p. 1554, doi. 10.1093/eurheartj/ehab804
- By:
- Publication type:
- Article
Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based?
- Published in:
- European Heart Journal, 2022, v. 43, n. 10, p. 1008, doi. 10.1093/eurheartj/ehab896
- By:
- Publication type:
- Article
Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 148, doi. 10.1093/eurheartj/ehab509
- By:
- Publication type:
- Article
Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.
- Published in:
- European Heart Journal, 2021, v. 42, n. 45, p. 4697, doi. 10.1093/eurheartj/ehab676
- By:
- Publication type:
- Article
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 44, p. 4245, doi. 10.1093/eurheartj/ehaa649
- By:
- Publication type:
- Article
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 42, p. 4114, doi. 10.1093/eurheartj/ehaa498
- By:
- Publication type:
- Article
Research in the Antipodes at Green Lane.
- Published in:
- European Heart Journal, 2020, v. 41, n. 42, p. 4081, doi. 10.1093/eurheartj/ehaa303
- By:
- Publication type:
- Article
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
- Published in:
- European Heart Journal, 2020, v. 41, n. 24, p. 2248, doi. 10.1093/eurheartj/ehz809
- By:
- Publication type:
- Article
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
- Published in:
- European Heart Journal, 2019, v. 40, n. 33, p. 2801, doi. 10.1093/eurheartj/ehz299
- By:
- Publication type:
- Article
Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective.
- Published in:
- European Heart Journal, 2019, v. 40, n. 24, p. e4, doi. 10.1093/eurheartj/ehq317
- By:
- Publication type:
- Article
Fourth universal definition of myocardial infarction (2018).
- Published in:
- European Heart Journal, 2019, v. 40, n. 3, p. 237, doi. 10.1093/eurheartj/ehy462
- By:
- Publication type:
- Article
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
- Published in:
- European Heart Journal, 2018, v. 39, n. 46, p. 4112, doi. 10.1093/eurheartj/ehy562
- By:
- Publication type:
- Article
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.
- Published in:
- European Heart Journal, 2017, v. 38, n. 37, p. 2813, doi. 10.1093/eurheartj/ehx250
- By:
- Publication type:
- Article
Trade-off ofmyocardial infarction vs. bleeding types onmortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.
- Published in:
- European Heart Journal, 2017, v. 38, n. 11, p. 804, doi. 10.1093/eurheartj/ehw525
- By:
- Publication type:
- Article
Endothelium-Dependent Dilation of the Coronary Arteries in Syndrome X: Effects of the Cold Pressor Test.
- Published in:
- Cardiology, 1997, v. 88, n. 5, p. 414, doi. 10.1159/000177370
- By:
- Publication type:
- Article
Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Tria.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 18, p. 1, doi. 10.1161/JAHA.122.029216
- By:
- Publication type:
- Article
B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart Disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Adding Insult to Injury: Are There Treatments for Myocardial Injury and Type 2 Myocardial Infarction?
- Published in:
- 2021
- By:
- Publication type:
- editorial
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 10, p. 1, doi. 10.1161/JAHA.116.005077
- By:
- Publication type:
- Article
Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 9, p. 1, doi. 10.1161/JAHA.117.006695
- By:
- Publication type:
- Article
Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
- Published in:
- Journal of the American Heart Association, 2016, v. 5, n. 11, p. 1, doi. 10.1161/JAHA.116.003977
- By:
- Publication type:
- Article
Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The roles for coronary surgery and angioplasty in the management of patients with stable angina:....
- Published in:
- Journal of Evaluation in Clinical Practice, 1998, v. 4, n. 2, p. 93, doi. 10.1111/j.1365-2753.1998.tb00073.x
- By:
- Publication type:
- Article
Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2379, doi. 10.1111/dom.13377
- By:
- Publication type:
- Article
LEFT VENTRICULAR FUNCTION FOLLOWING THROMBOLYTIC THERAPY FOR MYOCARDIAL INFARCTION.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 1995, v. 22, n. 3, p. 173, doi. 10.1111/j.1440-1681.1995.tb01975.x
- By:
- Publication type:
- Article
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction...
- Published in:
- JAMA: Journal of the American Medical Association, 1996, v. 275, n. 10, p. 777, doi. 10.1001/jama.1996.03530340041027
- By:
- Publication type:
- Article
Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trial.
- Published in:
- European Journal of Heart Failure, 2015, v. 17, n. 4, p. 453, doi. 10.1002/ejhf.256
- By:
- Publication type:
- Article
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context
- Published in:
- 2003
- By:
- Publication type:
- journal article
Adjunctive Use of Direct Thrombin Inhibitors in Patients Receiving Fibrinolytic Therapy for Acute Myocardial Infarction.
- Published in:
- American Journal of Cardiovascular Drugs, 2004, v. 4, n. 2, p. 107, doi. 10.2165/00129784-200404020-00004
- By:
- Publication type:
- Article
Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 16, p. 1408, doi. 10.1093/eurheartj/ehad144
- By:
- Publication type:
- Article
Utilisation and maintenance of high-intensity statins following acute coronary syndrome and coronary angiography: opportunities to improve care (ANZACS-QI 26).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Determining the In-Hospital Cost of Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
- Published in:
- Journal of Interventional Cardiology, 2009, v. 22, n. 3, p. 266, doi. 10.1111/j.1540-8183.2009.00431.x
- By:
- Publication type:
- Article